Torray Investment Partners LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 98758 Bethesda, MD

Position in VRTX

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$7,557,746

+$687,282 QoQ

Shares Held

15,215

-1.1% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

1.14%

of 13F equity value

Holder Rank

#413

of 1,742 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 90% Shared 0% None 10%

Healthcare · as of Jun 30, 2026

Torray Investment Partners LLC holds $61,710,475 across 8 Biotechnology names. VRTX ranks #2 (12.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	602,028	$33,755,709
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	15,215	$7,557,746
3	KRYS	Krystal Biotech, Inc.	12,156	$4,518,020
4	BMRN	Biomarin Pharmaceutical Inc	77,705	$4,446,280
5	AXSM	Axsome Therapeutics, Inc.	14,928	$3,653,926
6	HALO	Halozyme Therapeutics, Inc.	38,703	$3,029,283
7	SNDX	Syndax Pharmaceuticals Inc	133,835	$2,925,633
8	VSTM	Verastem, Inc.	477,455	$1,823,878

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,557,746	15,215	-1.1%	Shares	Sole	2026-07-30
2026-03-31	$6,870,464	15,386	-0.5%	Shares	Sole	2026-05-01
2025-12-31	$7,011,665	15,466	-4.9%	Shares	Sole	2026-01-28
2025-09-30	$6,366,108	16,255	-3.7%	Shares	Sole	2025-10-22
2025-06-30	$7,514,530	16,879	+7.4%	Shares	Sole	2025-08-05
2025-03-31	$7,621,855	15,721	-1.8%	Shares	Sole	2025-05-08
2024-12-31	$6,446,421	16,008	+1.6%	Shares	Sole	2025-02-06
2024-09-30	$7,325,475	15,751	+13.0%	Shares	Sole	2024-11-05
2024-06-30	$6,533,019	13,938	+0.3%	Shares	Sole	2024-08-06
2024-03-31	$5,809,920	13,899	-1.2%	Shares	Sole	2024-05-10
2023-12-31	$5,724,128	14,068	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.